The science around designing and testing smart-bomb chemotherapy has coalesced.
Public health officials must do more to counteract “rosé all day” and #winemom messaging.
Lecanemab is clearly a scientific breakthrough, but it's hard to quantify how meaningful it might be for any given patient.
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren't yet on board.
Please log back in before proceeding.
There was an error logging in. Please try again.
Congrats! You are now logged in. Your exam is being submitted.
